127 related articles for article (PubMed ID: 3524586)
1. The effects of mevinolin and neomycin alone and in combination on plasma lipid and lipoprotein concentrations in type II hyperlipoproteinemia.
Hoeg JM; Maher MB; Bailey KR; Brewer HB
Atherosclerosis; 1986 Jun; 60(3):209-14. PubMed ID: 3524586
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemia.
Hoeg JM; Maher MB; Zech LA; Bailey KR; Gregg RE; Lackner KJ; Fojo SS; Anchors MA; Bojanovski M; Sprecher DL
Am J Cardiol; 1986 Apr; 57(11):933-9. PubMed ID: 3515897
[TBL] [Abstract][Full Text] [Related]
3. Effects of combination cholestyramine-neomycin treatment on plasma lipoprotein concentrations in type II hyperlipoproteinemia.
Hoeg JM; Maher MB; Bailey KR; Zech LA; Gregg RE; Sprecher DL; Brewer HB
Am J Cardiol; 1985 May; 55(11):1282-6. PubMed ID: 3887883
[TBL] [Abstract][Full Text] [Related]
4. Normalization of plasma lipoprotein concentrations in patients with type II hyperlipoproteinemia by combined use of neomycin and niacin.
Hoeg JM; Maher MB; Bou E; Zech LA; Bailey KR; Gregg RE; Sprecher DL; Susser JK; Pikus AM; Brewer HB
Circulation; 1984 Dec; 70(6):1004-11. PubMed ID: 6388897
[TBL] [Abstract][Full Text] [Related]
5. Mevinolin plus colestipol in therapy for severe heterozygous familial hypercholesterolemia.
Illingworth DR
Ann Intern Med; 1984 Nov; 101(5):598-604. PubMed ID: 6567462
[TBL] [Abstract][Full Text] [Related]
6. Testicular function in type II hyperlipoproteinemic patients treated with lovastatin (mevinolin) or neomycin.
Farnsworth WH; Hoeg JM; Maher M; Brittain EH; Sherins RJ; Brewer HB
J Clin Endocrinol Metab; 1987 Sep; 65(3):546-50. PubMed ID: 3114306
[TBL] [Abstract][Full Text] [Related]
7. Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.
Illingworth DR; Sexton GJ
J Clin Invest; 1984 Dec; 74(6):1972-8. PubMed ID: 6569064
[TBL] [Abstract][Full Text] [Related]
8. Treatment of primary moderate hypercholesterolemia with lovastatin (mevinolin) and colestipol.
Vega GL; Grundy SM
JAMA; 1987 Jan; 257(1):33-8. PubMed ID: 3537351
[TBL] [Abstract][Full Text] [Related]
9. Normal cholesterol levels with lovastatin (mevinolin) therapy in a child with homozygous familial hypercholesterolemia following liver transplantation.
East C; Grundy SM; Bilheimer DW
JAMA; 1986 Nov; 256(20):2843-8. PubMed ID: 3534334
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy of once versus twice daily mevinolin in the therapy of familial hypercholesterolemia.
Illingworth DR
Clin Pharmacol Ther; 1986 Sep; 40(3):338-43. PubMed ID: 3638181
[TBL] [Abstract][Full Text] [Related]
11. Influence of lovastatin plus gemfibrozil on plasma lipids and lipoproteins in patients with heterozygous familial hypercholesterolemia.
Illingworth DR; Bacon S
Circulation; 1989 Mar; 79(3):590-6. PubMed ID: 2645064
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase by mevinolin in familial hypercholesterolemia heterozygotes: effects on cholesterol balance.
Grundy SM; Bilheimer DW
Proc Natl Acad Sci U S A; 1984 Apr; 81(8):2538-42. PubMed ID: 6371816
[TBL] [Abstract][Full Text] [Related]
13. Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.
Bilheimer DW; Grundy SM; Brown MS; Goldstein JL
Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4124-8. PubMed ID: 6575399
[TBL] [Abstract][Full Text] [Related]
14. Neomycin and plasma lipoproteins in type II hyperlipoproteinemia.
Hoeg JM; Schaefer EJ; Romano CA; Bou E; Pikus AM; Zech LA; Bailey KR; Gregg RE; Wilson PW; Sprecher DL
Clin Pharmacol Ther; 1984 Oct; 36(4):555-65. PubMed ID: 6383687
[TBL] [Abstract][Full Text] [Related]
15. Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment.
Gurakar A; Hoeg JM; Kostner G; Papadopoulos NM; Brewer HB
Atherosclerosis; 1985 Nov; 57(2-3):293-301. PubMed ID: 2935163
[TBL] [Abstract][Full Text] [Related]
16. Comparison of six pharmacologic regimens for hypercholesterolemia.
Hoeg JM; Maher MB; Bailey KR; Brewer HB
Am J Cardiol; 1987 Apr; 59(8):812-5. PubMed ID: 3644588
[TBL] [Abstract][Full Text] [Related]
17. Hypercholesterolemia persisting after distal ileal bypass: response to mevinolin.
Illingworth DR; Connor WE
Ann Intern Med; 1984 Jun; 100(6):850-1. PubMed ID: 6562870
[No Abstract] [Full Text] [Related]
18. Effect of colestipol and clofibrate, singly and in combination, on plasma lipid and lipoproteins in type IIb hyperlipoproteinemia.
Hunninghake DB; Bell C; Olson L
Metabolism; 1981 Jun; 30(6):610-5. PubMed ID: 7231198
[TBL] [Abstract][Full Text] [Related]
19. The effect of mevinolin on steroidogenesis in patients with defects in the low density lipoprotein receptor pathway.
Laue L; Hoeg JM; Barnes K; Loriaux DL; Chrousos GP
J Clin Endocrinol Metab; 1987 Mar; 64(3):531-5. PubMed ID: 3029155
[TBL] [Abstract][Full Text] [Related]
20. Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride.
Witztum JL; Simmons D; Steinberg D; Beltz WF; Weinreb R; Young SG; Lester P; Kelly N; Juliano J
Circulation; 1989 Jan; 79(1):16-28. PubMed ID: 2642754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
